New mRNA HIV vaccines enter human safety trial – could they teach the body to fight HIV?
NCT ID NCT07569029
First seen May 08, 2026 · Last updated May 25, 2026 · Updated 3 times
Summary
This early-stage study tests two new mRNA vaccines designed to help people with HIV produce antibodies against the virus. About 42 adults with well-controlled HIV will receive the vaccines and then temporarily pause their regular HIV medication under close monitoring. The main goal is to see if the vaccines are safe and whether they can trigger or strengthen the body's natural defenses against HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alabama CRS (Site ID: 31788)
Birmingham, Alabama, 35222, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Barranco CRS (Site ID: 11301)
Lima, 15063, Peru
Contact Phone: •••-•••-••••
-
Beth Israel Deaconess Medical Center / BIDMC VCRS (Site ID: 32077)
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS (CITBM) - Unidad de Ensayos Clínicos (UNIDEC) (Site ID: 31970)
Bellavista, Provincia Constitucional del Callao, 07006, Peru
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fundacion Huesped CRS (Site ID: 31957)
Buenos Aires, C1427CEA, Argentina
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
San Miguel CRS (Site ID: 11302)
Lima, 15088, Peru
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Seattle Vaccine and Prevention CRS (Site ID: 30331)
Seattle, Washington, 98109, United States
Contact Email: •••••@•••••
-
The Ponce de Leon Center CRS (Site ID: 5802)
Atlanta, Georgia, 30308, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Via Libre CRS (Site ID: 31909)
Lima, 15001, Peru
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.